METASTATIC BLADDER CANCER
Clinical trials for METASTATIC BLADDER CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC BLADDER CANCER trials appear
Sign up with your email to follow new studies for METASTATIC BLADDER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Bladder cancer combo shows promise in early trial
Disease control OngoingThis study tests whether adding the immunotherapy drug atezolizumab to standard chemotherapy (gemcitabine and cisplatin) is safe and effective for people with advanced bladder cancer. About 54 adults with metastatic or muscle-invasive bladder cancer will receive the combination. …
Matched conditions: METASTATIC BLADDER CANCER
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 17, 2026 02:14 UTC
-
Blood test may unlock targeted cancer drug for more bladder cancer patients
Diagnosis OngoingThis study looks at whether a blood test can better identify genetic changes in metastatic bladder cancer than the usual tumor tissue test. These changes determine if a patient can take the drug erdafitinib. Researchers will compare results from both tests in 260 patients to see …
Matched conditions: METASTATIC BLADDER CANCER
Sponsor: Bernie Eigl • Aim: Diagnosis
Last updated May 17, 2026 02:01 UTC